☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
BMS' Opdivo(nivolumab) Receives the US FDA's Approval for the Adjuvant Treatment of High-Risk Urothelial Carcinoma
August 23, 2021
BeiGene Reports NMPA's Acceptance of sBLA for Tislelizumab (BGB-A317) to Treat Nasopharyngeal Cancer in China
August 23, 2021
Pfizer's Xeljanz (tofacitinib citrate) Receives EC's Approval for the Treatment of Active Polyarticular JIA & Juvenile PsA
August 23, 2021
Zydus' ZyCoV-D Receives the DCGI's EUA for the Treatment of COVID-19
August 23, 2021
Alexion to Discontinue its P-III CHAMPION-ALS Trial of Ultomiris (ravulizumab) for Amyotrophic Lateral Sclerosis
August 23, 2021
Pfizer to Acquire Trillium for ~$2.26B
August 23, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions